Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Equity Ratio (2018 - 2025)

Neurogene (NGNE) has disclosed Equity Ratio for 5 consecutive years, with 0.92 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Equity Ratio rose 6.62% year-over-year to 0.92, compared with a TTM value of 0.92 through Jun 2025, up 6.62%, and an annual FY2024 reading of 0.92, changed N/A over the prior year.
  • Equity Ratio was 0.92 for Q2 2025 at Neurogene, down from 0.93 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q1 2025 and bottomed at 0.84 in Q3 2024.